These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 16328059)
1. Germ-line variants in methyl-group metabolism genes and susceptibility to DNA methylation in human breast cancer. Li SY; Rong M; Iacopetta B Oncol Rep; 2006 Jan; 15(1):221-5. PubMed ID: 16328059 [TBL] [Abstract][Full Text] [Related]
2. Germ-line variants in methyl-group metabolism genes and susceptibility to DNA methylation in normal tissues and human primary tumors. Paz MF; Avila S; Fraga MF; Pollan M; Capella G; Peinado MA; Sanchez-Cespedes M; Herman JG; Esteller M Cancer Res; 2002 Aug; 62(15):4519-24. PubMed ID: 12154064 [TBL] [Abstract][Full Text] [Related]
3. Polymorphism in folate- and methionine-metabolizing enzyme and aberrant CpG island hypermethylation in uterine cervical cancer. Kang S; Kim JW; Kang GH; Park NH; Song YS; Kang SB; Lee HP Gynecol Oncol; 2005 Jan; 96(1):173-80. PubMed ID: 15589597 [TBL] [Abstract][Full Text] [Related]
4. One-carbon metabolism-related gene polymorphisms and risk of breast cancer. Suzuki T; Matsuo K; Hirose K; Hiraki A; Kawase T; Watanabe M; Yamashita T; Iwata H; Tajima K Carcinogenesis; 2008 Feb; 29(2):356-62. PubMed ID: 18174236 [TBL] [Abstract][Full Text] [Related]
5. Methylenetetrahydrofolate reductase and thymidylate synthase polymorphisms are not associated with breast cancer risk or phenotype. Grieu F; Powell B; Beilby J; Iacopetta B Anticancer Res; 2004; 24(5B):3215-9. PubMed ID: 15510613 [TBL] [Abstract][Full Text] [Related]
6. The folate pool in colorectal cancers is associated with DNA hypermethylation and with a polymorphism in methylenetetrahydrofolate reductase. Kawakami K; Ruszkiewicz A; Bennett G; Moore J; Watanabe G; Iacopetta B Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5860-5. PubMed ID: 14676107 [TBL] [Abstract][Full Text] [Related]
7. Polymorphisms in methyl-group metabolism genes and risk of sporadic colorectal cancer with relation to the CpG island methylator phenotype. Karpinski P; Myszka A; Ramsey D; Misiak B; Gil J; Laczmanska I; Grzebieniak Z; Sebzda T; Smigiel R; Stembalska A; Sasiadek MM Cancer Epidemiol; 2010 Jun; 34(3):338-44. PubMed ID: 20381446 [TBL] [Abstract][Full Text] [Related]
8. Methionine-dependence phenotype in the de novo pathway in BRCA1 and BRCA2 mutation carriers with and without breast cancer. Beetstra S; Suthers G; Dhillon V; Salisbury C; Turner J; Altree M; McKinnon R; Fenech M Cancer Epidemiol Biomarkers Prev; 2008 Oct; 17(10):2565-71. PubMed ID: 18842997 [TBL] [Abstract][Full Text] [Related]
9. Polymorphisms of methylenetetrahydrofolate reductase (MTHFR), methionine synthase (MTR), methionine synthase reductase (MTRR), and thymidylate synthase (TYMS) in multiple myeloma risk. Lima CS; Ortega MM; Ozelo MC; Araujo RC; De Souza CA; Lorand-Metze I; Annichino-Bizzacchi JM; Costa FF Leuk Res; 2008 Mar; 32(3):401-5. PubMed ID: 17655928 [TBL] [Abstract][Full Text] [Related]
10. Methyl group metabolism gene polymorphisms as modifier of breast cancer risk in Italian BRCA1/2 carriers. Pepe C; Guidugli L; Sensi E; Aretini P; D'Andrea E; Montagna M; Manoukian S; Ottini L; Radice P; Viel A; Bevilacqua G; Caligo MA Breast Cancer Res Treat; 2007 May; 103(1):29-36. PubMed ID: 17151928 [TBL] [Abstract][Full Text] [Related]
11. One-carbon metabolism and breast cancer risk: no association of MTHFR, MTR, and TYMS polymorphisms in the GENICA study from Germany. Justenhoven C; Hamann U; Pierl CB; Rabstein S; Pesch B; Harth V; Baisch C; Vollmert C; Illig T; Brüning T; Ko Y; Brauch H Cancer Epidemiol Biomarkers Prev; 2005 Dec; 14(12):3015-8. PubMed ID: 16365030 [No Abstract] [Full Text] [Related]
12. Genetic polymorphisms of the enzymes involved in DNA methylation and synthesis in elite athletes. Terruzzi I; Senesi P; Montesano A; La Torre A; Alberti G; Benedini S; Caumo A; Fermo I; Luzi L Physiol Genomics; 2011 Aug; 43(16):965-73. PubMed ID: 21673074 [TBL] [Abstract][Full Text] [Related]
13. Methylation of estrogen and progesterone receptor gene 5' CpG islands correlates with lack of estrogen and progesterone receptor gene expression in breast tumors. Lapidus RG; Ferguson AT; Ottaviano YL; Parl FF; Smith HS; Weitzman SA; Baylin SB; Issa JP; Davidson NE Clin Cancer Res; 1996 May; 2(5):805-10. PubMed ID: 9816234 [TBL] [Abstract][Full Text] [Related]
14. Polymorphisms in one-carbon metabolism pathway genes and risk for bladder cancer in a Tunisian population. Rouissi K; Ouerhani S; Oliveira E; Marrakchi R; Cherni L; Ben Othman F; Ben Slama MR; Sfaxi M; Ayed M; Chebil M; Amorim A; Prata MJ; Benammar Elgaaied A Cancer Genet Cytogenet; 2009 Nov; 195(1):43-53. PubMed ID: 19837268 [TBL] [Abstract][Full Text] [Related]
15. Folic acid, polymorphism of methyl-group metabolism genes, and DNA methylation in relation to GI carcinogenesis. Fang JY; Xiao SD J Gastroenterol; 2003; 38(9):821-9. PubMed ID: 14564626 [TBL] [Abstract][Full Text] [Related]
16. One-carbon metabolism related gene polymorphisms interact with alcohol drinking to influence the risk of colorectal cancer in Japan. Matsuo K; Ito H; Wakai K; Hirose K; Saito T; Suzuki T; Kato T; Hirai T; Kanemitsu Y; Hamajima H; Tajima K Carcinogenesis; 2005 Dec; 26(12):2164-71. PubMed ID: 16051637 [TBL] [Abstract][Full Text] [Related]
17. MTR polymorphic variant A2756G and retinoblastoma risk in Brazilian children. de Lima EL; da Silva VC; da Silva HD; Bezerra AM; de Morais VL; de Morais AL; Cruz RV; Barros MH; Hassan R; de Freitas AC; Muniz MT Pediatr Blood Cancer; 2010 Jul; 54(7):904-8. PubMed ID: 20310006 [TBL] [Abstract][Full Text] [Related]
18. Association between polymorphisms of folate-metabolizing enzymes and risk of prostate cancer. Marchal C; Redondo M; Reyes-Engel A; Perea-Milla E; Gaitan MJ; Machuca J; Diaz F; Caballero J; Carnero J Eur J Surg Oncol; 2008 Jul; 34(7):805-10. PubMed ID: 17967524 [TBL] [Abstract][Full Text] [Related]
19. DNA hypermethylation in breast cancer and its association with clinicopathological features. Li S; Rong M; Iacopetta B Cancer Lett; 2006 Jun; 237(2):272-80. PubMed ID: 16029926 [TBL] [Abstract][Full Text] [Related]
20. GSTP1 promoter haplotypes affect DNA methylation levels and promoter activity in breast carcinomas. Rønneberg JA; Tost J; Solvang HK; Alnaes GI; Johansen FE; Brendeford EM; Yakhini Z; Gut IG; Lønning PE; Børresen-Dale AL; Gabrielsen OS; Kristensen VN Cancer Res; 2008 Jul; 68(14):5562-71. PubMed ID: 18632608 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]